Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
Clinical and Experimental Rheumatology|June 10, 2024
The change over time in the prescription pattern of the first targeted drug after failure of conventional therapy in patients with rheumatoid arthritis: a 20-year real-world experienceGabriella Maioli, Gilberto Cincinelli, Martina Biggioggero, et al.
Expert Opinion on Investigational Drugs|June 19, 2019
Mavrilimumab: a unique insight and update on the current status in the treatment of rheumatoid arthritisChiara Crotti, Martina Biggioggero, Andrea Becciolini, et al.
Drugs|September 6, 2019
Targeting Granulocyte-Monocyte Colony-Stimulating Factor Signaling in Rheumatoid Arthritis: Future ProspectsChiara Crotti, Elena Agape, Andrea Becciolini, et al.
Biomed Research International|November 9, 2018
The Management of Acute Anterior Uveitis Complicating Spondyloarthritis: Present and FutureMartina Biggioggero, Chiara Crotti, Andrea Becciolini, et al.
Drug Design, Development and Therapy|June 6, 2017
Profile of sarilumab and its potential in the treatment of rheumatoid arthritisMaria Gabriella Raimondo, Martina Biggioggero, Chiara Crotti, et al.
Drug Design, Development and Therapy|February 2, 2017
Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to dateChiara Crotti, Maria Gabriella Raimondo, Andrea Becciolini, et al.
Pediatric Rheumatology Online Journal|April 24, 2020
COVID-19 and what pediatric rheumatologists should know: a review from a highly affected countryFrancesco Licciardi, Teresa Giani, Letizia Baldini, et al.
Arthritis Research & Therapy|September 17, 2024
Truth unveiled by time and the marbled definition of D2T-RA: retrospective analysis on the persistence of the difficult-to-treat status among refractory RA patientsGilberto Cincinelli, Gabriella Maioli, Cristina Posio, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 8, 2020
Incidence of COVID-19 in Patients With Rheumatic Diseases Treated With Targeted Immunosuppressive Drugs: What Can We Learn From Observational Data?Ennio Giulio Favalli, Sara Monti, Francesca Ingegnoli, et al.
The Journal of Rheumatology|December 3, 2016
The 12-item Psoriatic Arthritis Impact of Disease Questionnaire: Construct Validity, Reliability, and Interpretability in a Clinical SettingMarco Di Carlo, Andrea Becciolini, Valentina Lato, et al.
Pageof 10